Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.49 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | PPARG | P37231 | 3/20 | 0.47 |
| ▸ | PPARD | Q03181 | 3/20 | 0.47 |
| ▸ | PPARA | Q07869 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1145294 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL10492001 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL10492147 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL10492034 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL21436107 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL6080699 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL1145369 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL11201395 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL711509 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 | |
| SCHEMBL8384794 | 1.00 | FAAH (0.54) | FAAHCES1HRH3TERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101679849-A | Fluorescent cell markers | ELENA KORCHAGINA | 2010-03-24 | — | — | CN | claimed |
| CN-101282985-A | Cell surface coating with hyaluronic acid oligomer derivative | KODE BIOTECH LTD (NZ) | 2008-10-08 | — | — | CN | claimed |
| CN-1938325-A | Synthetic membrane anchor points | KIWI INGENUITY LTD (NZ) | 2007-03-28 | — | — | CN | claimed |
| US-20230218577-A1 | USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-07-13 | — | — | US | disclosed |
| EP-3394080-B1 | LIPID-LINKED PRODRUGS | UNIV BRITISH COLUMBIA (CA) | 2023-06-07 | — | — | EP | disclosed |
| EP-3817725-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | Medesis Pharma (FR) | 2021-05-12 | — | — | EP | disclosed |
| EP-3710446-A1 | COMPOUNDS USEFUL FOR INHIBITING CDK7 | Eli Lilly and Company (US) | 2020-09-23 | — | — | EP | disclosed |
| US-10780174-B2 | Lipid-linked prodrugs | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2020-09-22 | — | — | US | disclosed |
| US-20200123188-A1 | SYNTHETIC MOLECULE CONSTRUCTS | KODE BIOTECH LIMITED (NZ) | 2020-04-23 | — | — | US | disclosed |
| EP-3635124-A1 | MICROORGANISMS FOR THE PRODUCTION OF INSECT PHEROMONES AND RELATED COMPOUNDS | Provivi, Inc. (US) | 2020-04-15 | — | — | EP | disclosed |
| WO-2020008032-A1 | TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE | MEDESIS PHARMA (FR) | 2020-01-09 | — | — | WO | disclosed |
| CN-101282985-B | Cell surface coating with hyaluronic acid oligomer derivative | KODE BIOTECH LTD | 2013-07-10 | — | — | CN | disclosed |
| CN-1809284-B | Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides | ENZYMOTEC LTD | 2011-05-11 | — | — | CN | disclosed |
| CN-101679849-A | Fluorescent cell markers | ELENA KORCHAGINA | 2010-03-24 | — | — | CN | disclosed |
| CN-101282985-A | Cell surface coating with hyaluronic acid oligomer derivative | KODE BIOTECH LTD (NZ) | 2008-10-08 | — | — | CN | disclosed |
| CN-1938325-A | Synthetic membrane anchor points | KIWI INGENUITY LTD (NZ) | 2007-03-28 | — | — | CN | disclosed |
| CN-1809284-A | Oils enriched with diacylglycerols and phytosterol esters for use in the reduction of blood cholestrol and triglycerides and oxidative stress | ENZYMOTEC LTD (IL) | 2006-07-26 | — | — | CN | disclosed |
| CN-1238520-C | Cytosolic phospholipase A2And methods of using the same to identify agonists and antagonists | GENETICS INST (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1348502-A | Crystal structure of cPLAz and methods of identifying agonists and antagonists using same | GENETICS INST (US) | 2002-05-08 | — | — | CN | disclosed |
| CN-1073979-A | A kind of phospholipase A 2The preparation method of inhibitor | LILLY CO ELI (US) | 1993-07-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10780174-B2 | Lipid-linked prodrugs | SGMS2, SGMS1, LIPA | FAAH 72/4885CES1 8/4885HRH3 2371/4885 |
| US-20230218577-A1 | USE OF HEAT SHOCK PROTEIN INHIBITORS FOR THE TREATMENT OF NEURODEVELOPMENTAL DISORDERS | HSP90AB1, HSP90AA1, HSF1 | FAAH 3435/4885CES1 4338/4885HRH3 4230/4885 |
| US-20200123188-A1 | SYNTHETIC MOLECULE CONSTRUCTS | PTDSS2, PTDSS1, UGCG | FAAH 139/4885CES1 251/4885HRH3 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.